Fulminant autoimmune Type 1 diabetes during interferon‐alpha therapy: a case of Th1‐mediated disease?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetic Medicine

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1464-5491.2001.00492.xPMID 11437866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.

  1999cited by this paper
• Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

  1998cited by this paper
• Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis.

  1998cited by this paper
• Diabetes Mellitus and Interferon Therapy

  1997cited by this paper
• IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2.

  1996cited by this paper
• A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

  1996cited by this paper
• Side effects of high-dose interferon therapy for chronic hepatitis C.

  1996cited by this paper
• Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2a

  1995cited by this paper
• Evaluation of Chest Pain in the Emergency Department

  1995cited by this paper
• Diabetes mellitus and interferon-alpha therapy.

  1995cited by this paper
• Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.

  1995cited by this paper
• Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia.

  1994cited by this paper
• Occurrence of IDDM during interferon therapy for chronic viral hepatitis.

  1994cited by this paper
• Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

  1993cited by this paper
• Induction of type I diabetes by interferon-alpha in transgenic mice.

  1993cited by this paper
• Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.

  1992cited by this paper
• Induction of hyperthyroidism by interferon-alpha-2b.

  1989cited by this paper
• INDUCTION OF HYPERTHYROIDISM BY INTERFERON-α-2b

  1989cited by this paper
• Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

  1985cited by this paper

• Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A Review.

  2022cites this paper
• Chapter 10 Diabetic Ketoacidosis

  2019cites this paper
• Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?

  2018cites this paper
• Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.

  2017cites this paper
• Interferon therapy in hepatitis C leading to chronic type 1 diabetes.

  2015cites this paper
• Régulation de la survie des cellules dendritiques plasmacytoïdes dans un contexte inflammatoire non viral

  2015cites this paper
• EFEITOS DA EXPOSIÇÃO AO DI-(2-ETILEXIL) FTALATO (DEHP) DURANTE A LACTAÇÃO E A PUBERDADE SOBRE A HOMEOSTASE GLICÊMICA E MATURAÇÃO SEXUAL DE RATOS

  2014cites this paper
• Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

  2014cites this paper
• Increased IFN-α–Producing Plasmacytoid Dendritic Cells (pDCs) in Human Th1-Mediated Type 1 Diabetes: pDCs Augment Th1 Responses through IFN-α Production

  2014cites this paper
• Augment Th 1 Responses through IFN-Th 1-Mediated Type 1 Diabetes : pDCs Dendritic Cells ( pDCs ) in Human Producing Plasmacytoid − α Increased IFN -

  2014cites this paper
• Hepatitis C virus and type 1 diabetes.

  2013cites this paper
• L’immunité innée dans le diabète sucré

  2013cites this paper
• Immunological alterations in hepatitis C virus infection.

  2013cites this paper
• Extrahepatic Manifestations of Chronic HCV

  2012cites this paper
• Type 1 Diabetes and Interferon Therapy

  2011cites this paper
• Drug-Induced Endocrine Autoimmunity

  2011cites this paper
• Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review

  2011cites this paper
• CHAPTER 42 – The Immunoendocrinopathy Syndromes

  2011cites this paper
• Type 1 Diabetes and Interferon Therapy A nationwide survey in Japan

  2011cites this paper
• Perspectives on endocrine disruptor effects on metabolic sensors.

  2011cites this paper
• A nationwide survey in Japan

  2011cites this paper
• Moyamoya in a child treated with interferon for recurrent osteosarcoma.

  2010cites this paper
• Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.

  2010cites this paper
• Association of pancreatic autoantibodies and human leukocyte antigen haplotypes with resolution of diabetes mellitus after therapy for hepatitis C virus infection in patients with HIV infection: case report and review of literature.

  2009cites this paper
• AUTOANTIBODIES IN HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE

  2008cites this paper
• A patient with chronic hepatitis C who did, and another who did not develop type 1 diabetes mellitus during interferon therapy: ironically the pre-treatment anti-GAD antibody was positive only in the latter

  2008cites this paper
• Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.

  2007influential citation
• A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?

  2007cites this paper
• Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.

  2007cites this paper
• Immunogenicity of xenopeptide hormone therapies.

  2006cites this paper
• Autoimmune Regulator Deficient Mice, an Animal Model of Autoimmune Polyendocrine Syndrome Type I

  2006cites this paper
• Diabetic ketoacidosis.

  2005cites this paper
• How can the innate immune system influence autoimmunity in type 1 diabetes and other autoimmune disorders?

  2005cites this paper
• Viral Protein VP4 Is a Target of Human Antibodies Enhancing Coxsackievirus B4- and B3-Induced Synthesis of Alpha Interferon

  2005cites this paper
• Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus.

  2005cites this paper
• Interferon-α therapy and Type 1 diabetes mellitus in patients with hepatitis C: pathophysiologic insights

  2005cites this paper
• 劇症1型糖尿病とHLA-DRB1 genotype

  2005cites this paper
• Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C

  2004cites this paper
• Antiviral therapy: role in the management of extrahepatic diseases.

  2004cites this paper
• Autoantikörper gegen Inselzellantigene und Diabetes mellitus Typ 1 unter Interferon alpha-Kombinationstherapie

  2004cites this paper
• [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].

  2004cites this paper
• T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes

  2004cites this paper
• Autoimmune polyendocrine syndromes.

  2004cites this paper
• Human T Cells and Dendritic Cells Subtypes in α Differential Responses to IFN -

  2003cites this paper
• A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy.

  2003cites this paper
• Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

  2003cites this paper
• Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases.

  2003cites this paper
• Differential responses to IFN-alpha subtypes in human T cells and dendritic cells.

  2003cites this paper
• The transient appearance of anti-GAD antibody in a type 2 diabetic patient with empyema.

  2003cites this paper
• A case of autoimmune polyglandular syndrome

  2003cites this paper
• Vogt‐Koyanagi‐Harada disease associated with interferon alpha‐2b/ribavirin combination therapy

  2003cites this paper
• Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells 12

  2003cites this paper
• Autoimmune Hepatitis: The Way We Were, the Way We Are Today and the Way We Hope to Be

  2002cites this paper
• Arthritis during interferon beta-1b treatment in multiple sclerosis

  2002cites this paper
• Autoimmune polyendocrine syndromes.

  2002cites this paper